| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| 16,16-dimethyl-pge2 | prostaglandin e2 receptor ep2 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Stem cells[MeSHID:D013234] |
NA | phase 2 | unknown |
| 16,16-dimethyl-pge2 | prostaglandin e2 receptor ep3 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Stem cells[MeSHID:D013234] |
NA | phase 2 | unknown |
| 16,16-dimethyl-pge2 | prostaglandin e2 receptor ep4 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Stem cells[MeSHID:D013234] |
NA | phase 2 | unknown |
| click here to return to the previous page | ||||||||